Mico Biomed Co. Ltd. (214610) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Mico Biomed Co. Ltd. (214610:KRX), powered by AI.

Current Price
₩2,290
P/E Ratio
-0.3
Market Cap
19.2B
Sector
Healthcare
What is the Mico Biomed Co. Ltd. stock price forecast?

Mico Biomed Co. Ltd. is currently trading at ₩2,290. View real-time AI analysis on Alpha Lenz.

What is Mico Biomed Co. Ltd. insider trading activity?

View the latest insider trading data for Mico Biomed Co. Ltd. on Alpha Lenz.

What is Mico Biomed Co. Ltd.'s P/E ratio?

Mico Biomed Co. Ltd.'s P/E ratio is -0.3.

Mico Biomed Co. Ltd.

KRX · 214610
₩2,290+0(+0.00%)Market closedKRX regular session 09:00–15:30 KST
Ask about Mico Biomed Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Mico Biomed Co. Ltd. trades at a P/E of -0.3 (undervalued) with modest ROE of -98.1%.

Ask for details

Company Overview

Mico Biomed Co. Ltd. is a prominent player in the biotechnology industry, specializing in the development and manufacturing of diagnostic solutions. The company's primary function involves the innovation and production of highly precise medical diagnostic devices and kits. These products are crucial for detecting and monitoring various diseases and conditions, offering significant contributions to healthcare provisioning and patient outcomes. Mico Biomed's offerings cater to a wide spectrum of needs within both clinical and point-of-care settings, allowing for timely and accurate diagnosis, which is essential for effective treatment planning. The company is known for its dedication to research and development, ensuring that its product lines remain at the forefront of technological advancements. By focusing on enhancing the accessibility and reliability of medical diagnostics, Mico Biomed Co. Ltd. holds a vital role in the healthcare sector, contributing to improved public health standards and supporting the broader medical industry in addressing healthcare challenges.

CEO이재성
SectorHealthcare
IndustryMedical Devices
Employees50

Company Statistics

FY 2024

Profile

₩19,197,807,380Market Cap
₩4,640,103,570Revenue
8.38MShares Out
50Employees

Margins

-129.69%Gross
-365.71%EBITDA
-414.43%Operating
-632.21%Pre-Tax
-685.40%Net

Valuation

-0.32P/E
0.39P/B
2.15EV/Sales
-1.04EV/EBITDA
-0.85P/FCF

Growth (CAGR)

-46.50%Rev 3Yr
2.52%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-54.94%ROA
-98.14%ROE
-48.31%ROIC

Financial Health

₩13,672,760,190Cash & Cash Equivalents
₩14,908,618,860Net Debt
110.42%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Mico Biomed Co. Ltd. (ticker: 214610) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 50 employees. Market cap is $19.2B.

The current price is ₩2,290 with a P/E ratio of -0.32x and P/B of 0.39x.

ROE is -98.14% and operating margin is -414.43%. Annual revenue is $4.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Mico Biomed Co. Ltd. (214610) Stock Forecast 2026 ₩2,290 — Price, Financials & Analyst Targets | Alpha Lenz